NYSEARCA:CTGO - NYSE Arca - US21077F1003 - Common Stock - Currency: USD
TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
Operating Expenses | 15.72M | 15.38M | 17.29M | 19.53M | 10.66M | |||
Research and Development | 5.00M | 4.65M | 8.41M | 9.14M | 300.00K | |||
Selling, General, and Administrative Expenses | 10.59M | 10.61M | 9.09M | 10.34M | 10.36M | |||
Operating Income | -15.72M | -15.38M | -17.29M | -19.53M | -10.66M | |||
Interest Income/Expense | -26.73M | -24.07M | -23.06M | -4.04M | 35.83M | |||
Other Income/Expense | N/A | 127.40K | 620.00K | 40.00K | N/A | |||
Non Recurring Items | N/A | 0.00 | -10.00K | -90.00K | N/A | |||
Income Before Taxes | -39.94M | -38.11M | -39.74M | -23.63M | 25.17M | |||
Income Tax | N/A | -83.40K | 0.00 | -120.00K | 1.30M | |||
Net Income | -40.08M | -38.03M | -39.74M | -23.51M | 23.87M | |||
EBITDA | -15.59M | -15.26M | -17.15M | -19.47M | N/A | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -3.71 | -3.49 | -5.61 | -3.49 | 3.82 | |||
Non GAAP EPS | -3.41 | -3.67 | -5.62 | N/A | N/A | |||
Statistics |
All data in USD